COMMUNIQUÉS West-GlobeNewswire

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
29/02/2024
DONESTA ® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA ® to treat vasomotor symptoms (VMS) in [...]
Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024
29/02/2024
February 29, 2024 New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips’ latest innovation leverages [...]
RAMSAY SANTE :half-year financial report as at end of December 2023 disposal
29/02/2024
Paris, February 29, 2024 RAMSAY SANTE Half-year Financial Report as at end of December 2023 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé : Ramsay Santé [...]
RAMSAY SANTE : mise à disposition du rapport financier semestriel au 31 décembre 2023
29/02/2024
Paris, le 29 février 2024 RAMSAY SANTE Mise à disposition du rapport financier semestriel au 31 décembre 2023 Ce document est disponible sur le site internet de RAMSAY SANTE : http://www.ramsaysante.fr A propos de [...]
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
29/02/2024
PDUFA Target Action Date for ensifentrine of June 26, 2024 Commercialization preparations advance Strong balance sheet supports commercialization and Company's growth Conference call today at 9:00 a.m. EST / 2:00 p.m. [...]
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
29/02/2024
Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2023 financial [...]
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
29/02/2024
Award gives priority US regulatory review to Company’s ARC-BCI™ System EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating [...]
argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
29/02/2024
$374 million in fourth quarter and $1.2 billion in full year global net product sales sBLA for VYVGART® Hytrulo for CIDP accepted for priority review by FDA with PDUFA target action date of June 21, 2024 On track to [...]
IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa
29/02/2024
Contract with IAEA demonstrates Cyclone ® KEY’s accessibility for low- and middle-income countries Louvain-la-Neuve, Belgium, February 29, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle [...]
IBA signe un contrat avec l’AIEA pour l'installation d'un Cyclone® KEY au Bénin, en Afrique de l'Ouest
29/02/2024
Ce contrat avec l’AIEA démontre l'accessibilité du Cyclone ® KEY pour les pays à revenu faible et intermédiaire Louvain-la-Neuve, Belgique, le 29 février, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), le leader [...]
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®
29/02/2024
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ ® Recommendation for use in travelers and laboratory workers follows U.S. Food and Drug Administration (FDA) approval [...]
Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ®, le vaccin à injection unique contre le chikungunya de Valneva
29/02/2024
Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ ® , le vaccin à injection unique contre le chikungunya de Valneva La recommandation pour l’utilisation chez les voyageurs [...]
BioSenic S.A. : Information on the total number of voting rights and shares
29/02/2024
PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 29 February 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and [...]
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
29/02/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 février 2024 à 07h00 CEST – BIOSENIC (Euronext Bruxelles et Paris: BIOS), la société en phase clinique spécialisée dans les maladies [...]
Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs
29/02/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Sandoz US to pay USD 265 million in exchange for full release of all claims by the class Resolves all federal antitrust damages for [...]
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling plant
29/02/2024
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling plant CARBIOS and Landbell Group sign agreement to develop and implement solutions for the sorting, preparation and [...]
CARBIOS et Landbell Group s’unissent pour accroître la circularité des déchets PET dans la première usine de biorecyclage
29/02/2024
CARBIOS et Landbell Group s’unissent pour accroître la circularité des déchets PET dans la première usine de biorecyclage CARBIOS et Landbell Group signent un accord pour le développement et la mise en œuvre de [...]
Arcutis Announces Pricing of $150 Million Public Offering
29/02/2024
WESTLAKE VILLAGE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Tilray fait le point sur la législation internationale concernant le cannabis suite à la légalisation historique du cannabis par l’Allemagne
29/02/2024
La déclassification du cannabis en Allemagne ouvre la voie à de nouvelles opportunités commerciales pour Tilray sur ce marché médical pouvant représenter jusqu’à 3 milliards de dollars Le marché du cannabis médical au [...]

Pages